ABclonal
Pre-clinicalABclonal provides validated antibodies, ELISA kits, and molecular biology reagents for apoptosis, immunology, and cancer research.
Founded
2011
Focus
Antibodies
About
ABclonal provides validated antibodies, ELISA kits, and molecular biology reagents for apoptosis, immunology, and cancer research.
Funding History
2Total raised: $292M
Series C$200MSequoia Capital ChinaDec 15, 2022
Series B$92MSequoia Capital ChinaAug 15, 2021
Company Info
TypePrivate
Founded2011
LocationWoburn, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile